Detalhe da pesquisa
1.
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).
Cancer
; 121(13): 2193-7, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827820
2.
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
Br J Haematol
; 165(4): 504-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24579885
3.
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.
Br J Haematol
; 167(2): 233-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039477
4.
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
J Clin Oncol
; 39(4): 285-294, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356422
5.
Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201.
J Clin Oncol
; 38(5): 472-479, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815582
6.
Association of immunophenotype with expression of topoisomerase II α and ß in adult acute myeloid leukemia.
Sci Rep
; 10(1): 5486, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218491
7.
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer.
Eur J Cancer
; 130: 219-227, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234665
8.
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
J Clin Oncol
; 37(13): 1062-1069, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817250
9.
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713.
Clin Colorectal Cancer
; 17(1): e121-e125, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233486
10.
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.
J Clin Oncol
; 35(15): 1695-1703, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28384065
11.
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial.
JAMA Oncol
; 3(4): 516-522, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27978579